- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Patients with relapsed/refractory DLBCL.
Total 195611 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Nervous System Lymphoma | Recurrent Primary Vitreoretinal DLBCL | Refractory Nervous System Lymphoma | Refractory Primary Vitreoretinal DLBCLUnited States
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
University of BolognaTerminated
-
CelltrionTerminatedDiffuse Large B-Cell LymphomaKorea, Republic of
-
Inje UniversityUnknownNon Hodgkin's LymphomaKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-Cell Lymphoma | Sintilimab | TP53 Mutation
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cell LymphomaItaly
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Sichuan UniversityUnknown
-
National Research Center for Hematology, RussiaNational Research Center for HematologyRecruiting
-
Ruijin HospitalNot yet recruitingDiffuse Large B Cell Lymphoma
-
Sierra Oncology LLC - a GSK companyCompletedLymphoma, Diffuse Large B-CellUnited States, Puerto Rico
-
Peking University Cancer Hospital & InstituteUnknownLymphoma, Large B-Cell, DiffuseChina
-
AstraZenecaCompletedDiffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
Amgen Research (Munich) GmbHCompletedDiffuse Large B-cell LymphomaGermany
-
Peking University Cancer Hospital & InstituteUnknownLymphoma, Large B-Cell, DiffuseChina
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
Rush University Medical CenterElsa U. Pardee FoundationTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Rush University Medical CenterTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
University of RochesterGenentech, Inc.RecruitingLymphoma, B-Cell | DLBCLUnited States
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
The First Affiliated Hospital of Soochow UniversityRecruitingNon-GCB/ABC Diffuse Large B-Cell LymphomaChina
-
BayerCompletedNeoplasmsSingapore, United States, Korea, Republic of, Taiwan
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)Italy
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
MedImmune LLCCompletedRelapsed/Refractory Aggressive B-cell LymphomasUnited States
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-cell LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSTerminated
-
Hoffmann-La RocheCompletedLymphoma, Large B-Cell, DiffuseChina
-
Fudan UniversityTerminated
-
Astex Pharmaceuticals, Inc.Active, not recruitingLymphoma | Solid TumorsUnited States, Belgium, Spain, Hungary, Italy, Canada, United Kingdom, France
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Sun Yat-sen UniversityNot yet recruiting
-
Chonnam National University HospitalConsortium for Improving Survival of LymphomaUnknown
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedDLBCLBulgaria, Estonia, France, Hungary, Italy, Latvia, Poland, Russian Federation, Spain, Ukraine
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompletedLymphoma, Large B-Cell, DiffuseAustria
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France